| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fce22ba7fc6b22597697d3ff07c6b68 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 |
| filingDate |
1990-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328a90b3b5cc41785677e4c690e9280e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e7a03f02ec3ca534099bd66e7326d3e |
| publicationDate |
1992-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5116818-A |
| titleOfInvention |
Method and kit for contraception with GnRH-antagonist |
| abstract |
A method of providing contraception for and regulation of the menstrual cycle of a gonadal female mammal by a) administering thereto about once a week throughout her menstrual cycle an amount of a GnRH-antagonist effective to block folliculogenesis and thereby achieve a contraceptive state but less than the amount thereof required to block hormonogenesis; and b) inducing menses by administering during the last half of that cycle an amount of a progestin effective to produce a secretory endometrium and then terminating the progestin administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE40119-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5519002-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5663145-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7704983-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7538099-B1 |
| priorityDate |
1987-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |